// App-Quantinova.ai

1199 : Efficacy and Safety of Pemetrexed Combined with Lenalidomide in the Treatment of Relapsed/Refractory Primary Central Nervous System Lymphoma

Researchers

Presenter

  • Jingjing Ma

Principal Investigators

  • Bobin Chen

  • Lin Zhiguang

  • Qing Li

  • Hui Kang

  • Yan Ma

Medical Centers

  • Department of Pathology, Zhong Shan Hospital, Fudan University, Shanghai, China

  • Department of Pathology, Zhong Shan Hospital, Fudan University, Shanghai, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Primary central nervous system lymphoma

  • Venous thrombosis

  • Lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Lenalidomide

  • FA-8

  • Pemetrexed

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved